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Objective: It is known that bone mineral density (BMD) and the strength of bone is predicted by body mass. Fat 
mass is a significant predictor of bone mineral density which correlates with body weight. This suggests that 
body fat regulates bone metabolism first by means of hormonal factors and second that the effects of muscle and 
loading are signaling factors in mechanotransduction. Leptin, a peptide hormone produced predominantly by 
white fat cells, is one of these hormonal factors. The aim of this study was to investigate and measure by 
micro-CT the different effects of weight-bearing on trabecular bone formation in mice without the stimulation of 
leptin. 
Results: Animals with an ad-libitum-diet (Group A) were found to increase body weight significantly at the age 
of six weeks in comparison with lean mice (Group B). From this point on, the difference increased constantly. At 
the age of twenty weeks the obese mice were almost twice as heavy as the lean mice. Significant statistical 
differences are shown between the two groups for body weight and bone mineral density. Examination of 
trabecular bone (BV/TV, trabecular number (Tb.N.), trabecular thickness (Tb.Th.)) revealed that the only 
statistically significant difference between the two groups was the Tb.N. for the proximal femur. High 
weight-bearing insignificantly improved all trabecular bone parameters in the obese mice. Compared with the 
control-diet Group B, the BV/TV and Tb.N. were slightly higher in the controlled-diet Group A, but not the 
Tb.Th.. However, correlation was found between Tb.N. and BMD on the one hand and body weight on the other 
hand.  
Conclusion: biomechanical loading led to decreased bone mineral density by a decrease in the number of 
trabeculae. Trabecular thickness was not increased by biomechanical loading in growing mice. Decreased body 
weight in leptin-deficient mice protects against bone loss. This finding is consistent with the principle of 
light-weight construction of bone. Differences in cortical and trabecular bone will be examined in later studies. It 
is not possible to conclude that these results also apply to human beings. 
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Introduction 
It is known that bone mineral density (BMD) and 
the strength of bone is predicted by body mass. Reid et 
al. found that fat mass alone was a significant predictor 
of bone mineral density [1]. Fogelholm et al. showed 
that the bone mineral density in the non-weight 
bearing bone of the distal radius was more strongly 
correlated with body weight than bone mineral 
density in the weight-bearing bones of the hip and 
spine [2]. In our study we have shown the discrepancy 
in bone formation in the limbs and spine [3]. This 
suggests that first body fat regulates bone metabolism 
by means of hormonal factors, and second the effects 
of muscle and loading are signaling factors in 
mechanotransduction [4, 5]. Leptin, a peptide hormone 
produced predominantly by white fat cells, is one of 
these hormonal factors [6-11]. Recent data suggest that 
leptin may regulate a variety of other physiological 
processes, such as insulin action [12], hematopoiesis 
[13], immune function [14], reproduction [15] and 
angiogenesis [16]. Leptin inhibits appetite; 
consequently, mice with deficiency of leptin (ob/ob) or 
its receptor (db/db) are obese [7]. Takeda et al. and 
Karsenty described the leptin-dependent central 
control of bone remodeling via the sympathetic 
nervous system [11, 17-19]. The sterility of ob/ob mice 
should increase bone resorption and indeed, osteoclast 
numbers and parameters of bone resorption increased 
in ob/ob mice. Nevertheless, leptin-deficient mice 
h a v e  a  h i g h e r  b o n e  m a s s  t h a n  w i l d - t y p e  m i c e  a n d  
completely correct their high bone mass by 
intracerebroventricular infusion of leptin at a rate that 
does not result in any detectable leak of leptin in 
general circulation [20].  Int. J. Biol. Sci. 2008, 4 
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However, it is not clear whether leptin is a 
stimulator or an inhibitor of bone growth in humans. 
Some investigators noted a positive relationship 
between serum leptin levels and bone mineral density 
[21, 22], whereas others observed a negative 
relationship [23, 24]. Furthermore, no associations 
between serum leptin levels and bone mineral density 
have been reported [25, 26], which further confounds 
the interpretation of leptin’s effect on bone mass. Only 
a few studies in humans have examined the direct 
effect of leptin administration on bone mineral density 
in the early stages of life. Ogueh et al. noted  a 
significant negative correlation between fetal blood 
levels  of leptin and cross-linked carboxyl-terminal 
telopeptide of  Type 1 collagen (a marker of bone 
resorption). A modest negative correlation was also 
noted between leptin levels and the concentration of 
carboxyl-terminal pro-peptide of Type 1 collagen (a 
marker  of bone formation), but the researchers 
speculated that the overall effect of leptin on fetal bone 
metabolism was to increase bone mass by decreasing 
bone resorption [27]. One study reported an increase in 
bone mass and decrease in bodyweight after long-term 
leptin therapy in an obese 9-year-old girl with 
congenital leptin deficiency [28]. This might show the 
positive effect on bone formation in the early stages of 
development. Simha et al. concluded that the effect of 
leptin on bone metabolism may depend on the stage of 
life in humans [29].  
In a few recent reports the animal model was a 
useful surrogate to investigate the mechanism of 
leptin. Both leptin and its receptors were found in 
murine fetal cartilage and bone template, as well as in 
the growth plate [30]. In addition, leptin increased 
both proliferation and differentiation of the 
chondrocyte population of skeletal growth centers in 
organ cultures [31, 32]. All these strongly supported 
the theory that leptin could stimulate bone growth in 
the early stages of life.  
In general, mechanical loading stress on bones 
causes tissue deformation within the bone and 
stimulates the bone to adapt by remodeling to 
accommodate these demands, ultimately improving 
resistance to osteoporosis. Forwood et al. hypothesized 
that strain rate determines osteoblast recruitment in a 
vivo 4-point bending model in adult rat tibia [33, 34]. 
While previous studies have shown that bone 
parameters improved with weight-bearing exercise in 
normal subjects, we were interested in the co-influence 
of biomechanical loading on body weight and bone 
metabolism in subjects with leptin deficiency. There is 
so far no agreement regarding the positive effect of 
leptin in the early stages of life.  
The ability of three-dimensional micro-computed 
tomography to detect changes in a rat model was 
evaluated and compared with dual x-ray 
absorptiometry for bone mass, and bone 
histomorphometry for bone mass [35-41]. 
The aim of this study was to investigate the 
differential effects of weight-bearing on trabecular 
bone formation in mice without the stimulation of 
leptin.  
Materials and Methods  
Animals 
C57BL/6J-Lepob (ob/ob) female mice were 
received from the Janvier Laboratory (Le Genest St 
Isle, France) at the age of five weeks. The animal 
experiment was approved by the University`s ethics 
committee and the local authorities according to the 
official guidelines.  
The effects of dietary restriction in ob/ob and 
wild-type mice has been described in several studies 
[42-44]. The animals were housed one per cage with 
access to water ad libitum and a standard rodent diet 
(8640 Harlan Teklad 22/5[W]; Harlan Teklad, 
Madison, WI, USA) containing 1.13% calcium and 
0.94% phosphorus. The animals were maintained 
under conditions of a twelve-hour light and dark cycle 
with the light switched on at 6.00 a.m.. Food intake and 
body weight were recorded daily. There were two 
experimental groups divided according to the 
provision of food. Group A included 20 ob/ob mice 
with access to food ad libitum, the other 20 ob/ob mice 
in Group B received a limited amount of food (6 gr. 
each day). All the animals were euthanized by 
mechanical procedure at the age of twenty weeks. 
Micro-CT 
  A high resolution micro-CT (SkyScan 1072, 
Aartselaar, Belgium) was used to perform qualitative 
and quantitative analysis of the hip and knee. All 
samples were scanned by a commercially available 
microcomputed tomographic scanner at the 
Department of Cardiology of the West German Heart 
Centre at the University of Duisburg-Essen.  
Technical specifications of the micro-CT 
  The micro-CT system is based on a scanner 
developed for high-resolution imaging (up to 4 µm 
cubic voxels) of sample sizes up to 2 cm3. The scanner 
uses a field x-ray tube with an 8 µm spot-seize and 
expected lifetime of > 10,000 hours. The tube is 
operated at between 20 and 100 kiloelectron volts and 
a current of up to 100 micro amperes. For scanning, the 
samples are placed between the microfocus X-ray 
source and a Charge-Coupled-Device (CCD) detector 
(matrix size: 1024 x 1024 pixels, field of view: 25 mm2). 
In order to prevent samples from moving during Int. J. Biol. Sci. 2008, 4 
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scanning, the limbs are placed in a tightly fitting rigid 
plastic tube. In the scanner’s chamber the specimens 
are placed on a stack of computer-controlled precision 
stages which are rotated in equiangular steps of 0.9° 
around an angle of 180°. When the object is placed 
between the X-ray source and the CCD-detector, the 
cone-beam of X-rays passes the object and then hits the 
CCD-detector producing 2D-X-ray images. A personal 
computer is used to control the scanner and store the 
CCD image data recorded at each angle of view during 
the scanning process.  
Tomographic image reconstruction 
The X-ray projection data of the scanned samples 
are then submitted to the resident reconstruction 
program (Cone-beam Reconstruction, Skyscan, 
Aartselaar, Belgium), which is based on a Feldkamp 
filtered back projection algorithm [45] resulting in a 
volume image of up to 10,243 voxels, each cubic voxel 
being 4–19 µm on one side, depending on how much of 
the specimen has to be imaged.  
Cancellous bone assessment by micro-CT 
Three regions of interest (ROIs) from the 
proximal femur and tibia were selected for structural 
analysis of the cancellous bone. A cubic region of 0.5×
0.5 × 0.5mm3 in the metaphysis of the tibia was 
adjacent to (1mm away from) the growth plate and 
femoral head. Bone volume ratio (BV/TV) was 
calculated by adding the number of voxels 
representing mineralized trabecular bone divided by 
the total volume, and expressed as a percentage. 
Trabecular thickness (Tb. Th) and trabecular number 
( T b . N )  w e r e  b a s e d  d i r e c t l y  o n  t h e  3 - D  d a t a  u s i n g  
medial axis transformation and distance 
transformation.  
Statistical analysis 
Data were analyzed and assessed using SPSS 
software (version 15.0; SPSS Institute Inc, Chicago, 
USA). Descriptive statistics of all variables were 
determined including the mean and standard 
deviation of each group. The difference of all 
parameters between the two groups was assessed by 
the Student`s t-Test because all parameters (were 
normally distributed which was tested with the 
Kolmogorov Smirnov test). Pearson's correlation 
coefficient was used to assess the relationship between 
all the trabecular bone parameters of femur and tibia. 
A value of p ≤0.05 was considered to be statistically 
significant.  
Results 
No death or health deterioration occurred during 
this study. The body weight at each time point in the 
two groups is shown in Figure 1.  
 
Fig. 1: The curves show the change in body-weight in the two 
groups. In Group A the animals had an ad-libitum-diet with a 
body weight over 50 grams after 20 weeks, the animals in Group 
B a controlled diet with a body weight over 35 grams after 20 
weeks. Inter-group difference was already significant at the age 
of six weeks (p＜0.05).  
 
Animals with an ad-libitum-diet (Group A) were 
found to increase body weight significantly at the age 
of six weeks in comparison with the lean mice (Group 
B). From this time point on, the difference increased 
constantly. At the age of twenty weeks the obese mice 
were almost twice as heavy as the lean mice. 
Micro-CT measurements were obtained for 
assessment of the morphological changes in the two 
groups (Fig. 2). 
 
Fig. 2: Three-dimensional images of all the ROIs of the mice in 
Groups A and B at the age of 20 weeks. The upper frame is the Int. J. Biol. Sci. 2008, 4 
 
172
ROI of the proximal femur and the below frame the ROI of the 
proximal tibia. 
 
Statistically significant differences in body weight 
and bone mineral density between the two groups are 
shown in Table 1.  
Table 1: Statistically significant differences between the 
ad-libitum-diet Group A and controlled-diet Group B for bone 
mineral density (BMD) and body weight (p < 0.05) at age of 20 
weeks. 
 
Group  
BMD  
mean 
  
 SD  
Weight 
(grams) 
mean  
 
 SD 
Group A (n=20) 
(diet ad libitum ) 
2.57 0.147 52.53  6.36 
Group B (n=20) 
(control diet) 
2.68 0.138 35.65  3.50 
P value  0.022  < 0.001 
 
Examination of trabecular bone (BV/TV, 
trabecular number (Tb.N.), trabecular thickness 
(Tb.Th.)) revealed that the only statistically significant 
difference between the two groups was the trabecular 
number (Tb.N.) for the proximal femur. High 
weight-bearing insignificantly improved all trabecular 
bone parameters in the obese mice. Compared with the 
controlled-diet Group B, the BV/TV and trabecular 
number (Tb.N.) were slightly higher in the 
ad-libitum-diet Group A, but not the trabecular 
thickness (Tb.Th.) for the proximal tibia (Table 2).  
Table 2: Cross-section structural geometric properties of the 
femur and tibia were evaluated using micro-CT. Note: Summary 
of morphometric characteristics in the two groups which were 
different in body weight-bearing. 
*A statistically significant 
difference was detected between the two groups only in 
trabecular number (Tb.N.) of the femur (p < 0.05) at age of 20 
weeks. 
 
Position
 
Group  
BV/TV 
(%)  
  
SD 
Tb.Th 
(mm) 
 
SD 
Tb.N 
(1/mm)
 
SD 
Femur Group A 
(n=20) 
(ad-libitum 
diet) 
60.66 6.13  0.094  0.0069 6.42 0.45 
 Group  B 
(n=20) 
(controlled 
diet) 
62.76 6.5  0.093  0.0075 6.76 0.55 
 P  value 0.347  0.412  0.038* 
Tibia Group  A 
(n=20) 
(ad-libitum 
diet) 
52.75 3.94  0.094  0.0063 5.63 0.34 
 Group  B 
(n=20) 
(controlled 
diet) 
54.64 7.48  0.093  0.0084 5.90 0.52 
 P  value 0.325  0.561  0.058 
 
Correlation was found between trabecular 
number (Tb.N.) and bone mineral density (BMD) 
(measured by micro-CT) and body weight (Figs. 3 and 
4). 
 
 
Figure 3: The correlation between trabecular number (Tb.N.) and body weight shows an significant decrease in trabecular number as 
body weight increases (p < 0.01) in both groups (n =40). Int. J. Biol. Sci. 2008, 4 
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Figure 4: The correlation between bone mineral density (BMD) and body weight shows an significant decrease in BMD as body 
weight increases (p < 0.01) in both groups (n=40). 
 
Discussion 
In our study biomechanical loading led to 
decrease bone mineral disease and trabecular number 
in leptin-deficient mice. A great deal of research has 
confirmed that increased biomechanical loading due to 
increased body weight contributes to the increased 
bone dimensions and mass observed not only in our 
animal model but also in obese humans. At the same 
time, the increased biomechanical loading due to 
increased body weight contributed to an increased 
bone mass as a co-influence. Increased bone mineral 
density in childhood obesity was therefore revealed 
both in the weight-bearing limbs and the unloaded 
arms [46].   
Increased loading of long bones produces the 
greatest mechanical stress on the subperiosteal surface 
and stimulates bone formation by subperiosteal 
expansion [47]. A quantitative computertomography 
(qCT) study in healthy children suggested that 
weight-bearing and mechanical stresses are important 
determinants of cortical bone mass, whereas bone 
mineral density of trabecular bone is influenced by 
hormonal factors associated with sexual development 
[48]. A study of bone biomechanics in adult rats with 
diet-induced obesity showed significantly greater bone 
strength in the obese rats than in the controls [49]. The 
cross-sectional geometry and ultimate fracture load of 
the femur were higher in the obese rats than in the 
controls. Tromp et al. suggests that the effect of 
mechanical loading in the rat-with-backpack model 
mainly occurs at cortical bone sites and not in 
trabecular metaphyseal bone [35, 36]. The tibial 
proximal metaphysis is selected for the high cancellous 
bone compound and is used to explain the effects of 
disuse, ovariectomy and hormones [50-53]. We could 
not eliminate the possible effect of other factors on 
bone mineral density, such as oestrogen. Oestrogen 
was confirmed to be present in postmenopausal obese 
females at a relatively higher serum level because 
adipocytes were a major site of oestrogen production 
in these subjects [54, 55]. But the mice in our study 
were no more than twenty weeks old (in the pubertal 
stage) and without ovariectomy. Thus, oestrogen due 
to adipocytes is not a very likely confounding factor in 
our study.  
Leptin deficiency results in low sympathetic tone, 
and genetic or pharmacological ablation of adrenergic 
signaling leads to a leptin-resistant high bone mass. 
Β-adrenergic receptors on osteoblasts regulate their 
proliferation, and a β-adrenergic agonist decreases the 
bone mass in leptin-deficient and wild-type mice, 
while a β-adrenergic antagonist increases bone mass in 
wild-type and ovariectomized mice. None of these 
manipulations affects body weight. Therefore we used Int. J. Biol. Sci. 2008, 4 
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only leptin-deficient mice in a dietary model. This 
study of Takeda et al. demonstrates a leptin-dependent 
neuronal regulation of bone formation with potential 
therapeutic implications for osteoporosis [18].   
In our study, however, there were only 
insignificant trends in trabecular bone mass between 
the ad-libitum-diet, leptin-deficient obese mice and the 
controlled-diet, leptin-deficient mice. In other words, it 
seemed that increased biomechanical loading due to 
increased body weight did not contribute to increased 
bone dimensions in the leptin-deficient subjects. In 
contrast, Hamrick et al. showed that the endocortical 
mineralizing surface, serum leptin, body weight, and 
percentage of body fat in C57BL/6 mice all increased 
between the age of six and twelve months as the 
activity level of the mice declined [10].  
We considered that our results did not negate the 
conclusion of other researchers regarding the positive 
effect of biomechanical loading on bone mass, but 
none of these studies focused on leptin-deficient 
subjects [56]. The new finding of our study, which 
focused on the co-influence of biomechanical loading 
in subjects with leptin deficiency, is that it confirmed 
the presence of leptin as the pre-condition for a 
positive trend between loading and bone mass, in 
contrast to what has been reported in the literature so 
far [44, 56]. We hypothesized that biomechanical 
loading due to body weight might be a factor which 
has led to the contradictory results regarding bone 
mineral density in studies with mice which were either 
not known to be deficient in leptin or had inactive 
leptin receptors. 
The data gathered during some research studies 
appear conflicting or even contradictory. Ducy et al. 
observed that three- and six-month old obese ob/ob 
mice, which were deficient in leptin, and diabetic 
db/db mice, which have a mutated and inactive leptin 
receptor, had higher bone mineral density of 
trabecular bone associated with a higher mineral 
apposition rate compared to their wild-type 
litter-mates [20]. On the other hand, Foldes et al. [57] 
showed that obese fatty fa/fa rats, which also had a 
mutated leptin receptor, had a lower bone mass with 
shorter and lighter femurs compared to their normal 
litter-mates. Lower femoral bone mineral density and 
osteocalcin (a marker of bone formation) serum were 
described in fa/fa rats, as well as decreased trabecular 
bone volume, trabecular thickness and trabecular 
number, as measured both by micro-CT and 
histomorphometry [58, 59].  
In summary, biomechanical loading led to 
decreased bone mineral density by a decrease in the 
number of trabeculae. Trabecular thickness was not 
increased by biomechanical loading in growing mice. 
Decreased body weight in leptin-deficient mice 
protects against bone loss. This finding is consistent 
with the principle of light-weight construction of bone. 
Differences in cortical and trabecular bone will be 
examined in later studies. It is not possible to conclude 
that these results also apply to human beings. 
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